AngioDynamics, Inc. ANGO
Set alert
11.76 USD -0.23 -1.92%
At close · Nov 2
11.76 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
11.66 Day range 12.32
9.39 52-week range 16.29
- YTD
- -8.41%
- 1 year
- -2.24%
- Open
- 12.00
- Prev close
- 11.99
- Mkt cap
- 494.56M
- Vol
- 456.63K
- Avg vol
- 643.17K
- EPS
- -0.78
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 11.66
- High
- 12.32
- Forward P/E
- -36.21
- Beta
- 0.67
- Short ratio
- 2.88
- Inst. own
- 81.31%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jan 8, 2025
- 50-d avg
- 7.35
- 200-d avg
- 6.77
- 1y target
- 13.00
6M chart
Signals (30)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 23, 2026 | 1 week ago |
| SMA: Bearish | Oct 8, 2026 | 3 weeks ago |
| RSI: Oversold | Oct 8, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 6, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 20, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 19, 2026 | 2 months ago |
| RSI: Overbought | Aug 19, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 18, 2026 | 2 months ago |
| RSI: Overbought | Aug 7, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 28, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 23, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 15, 2026 | 3 months ago |
| RSI: Overbought | Jul 15, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 8, 2026 | 3 months ago |
| RSI: Overbought | Jun 25, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 22, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 17, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 5, 2026 | 5 months ago |
| SMA: Bullish | Jun 2, 2026 | 5 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| MACD: Sell Signal | Jun 1, 2026 | 5 months ago |
| MACD: Buy Signal | May 19, 2026 | 5 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| SMA: Bearish | May 15, 2026 | 5 months ago |
| SMA: Bullish | May 14, 2026 | 5 months ago |
| MACD: Sell Signal | May 12, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bullish | May 7, 2026 | 5 months ago |
Financial health
Altman Z-Score
2.46 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 2
Valuation
P/E -12.4×
FY 2017 5y median -12.3× FY 2026
P/S 1.4×
FY 2017 5y median 1.4× FY 2026
P/B 2.7×
FY 2017 5y median 1.8× FY 2026
P/FCF 892×
FY 2017 5y median -28.6× FY 2026
EV/EBITDA 818×
FY 2017 5y median 69.2× FY 2026
EV/Sales 1.2×
FY 2017 5y median 1.2× FY 2026
FCF Yield 0.1%
FY 2017 5y median -1.5% FY 2026
Profitability
Gross Margin 54.6%
FY 2017 5y median 52.4% FY 2026
Operating Margin -12.5%
FY 2017 5y median -13.7% FY 2026
Net Margin -11.5%
FY 2017 5y median -11.6% FY 2026
ROE -21.5%
FY 2017 5y median -18.6% FY 2026
ROIC -20.7%
FY 2017 5y median -19.4% FY 2026
ROA -13.8%
FY 2017 5y median -12.1% FY 2026
Growth (YoY)
Revenue 9.5%
FY 2017 FY 2026
Operating Income 0.1%
FY 2017 FY 2026
EPS (diluted) -6.0%
FY 2017 FY 2026
Free Cash Flow 103.5%
FY 2017 FY 2026
Financial Health
Current Ratio 2.2×
FY 2017 5y median 2.1× FY 2026
Quick Ratio 1.5×
FY 2017 5y median 1.4× FY 2026
Debt / Equity 0.0×
FY 2017 5y median 0.1× FY 2026
Net Debt / EBITDA -110×
FY 2017 5y median 0.4× FY 2026
Interest Coverage -134×
FY 2017 5y median -18.9× FY 2026
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2026
Annual · latest fiscal year ends 2026-05-31